Clínica Médica
[Preprint] Estudo sugere que a subvariante BA.2 do SARS-CoV-2 é ainda mais transmissível do que a variante Ômicron original.
4 Fev, 2022 | 15:08hComentários:
Study suggests BA.2 COVID-19 subvariant more contagious – CIDRAP
‘Stealth Omicron’ spreads more than original strain: study – MedicalXpress
Comentário do autor no Twitter (fio – clique para saber mais)
New Preprint Out!
“Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households”
We investigate the secondary attack rate (SAR) in #Omicron BA.1 vs. BA.2 households in Demark, 20 December 2021 – 18 January 2022.https://t.co/F3XBH2LnW9
1/ pic.twitter.com/MwGPNYkOg8— Frederik Plesner Lyngse (@LyngseF) January 31, 2022
Consenso | Nefrotoxinas e lesão renal aguda.
4 Fev, 2022 | 15:01hRecomendações sobre o tratamento de pacientes com espondiloartrites, incluindo artrite psoriática.
4 Fev, 2022 | 14:58hM-A | Vasopressina e glicocorticoides na parada cardíaca em pacientes internados.
4 Fev, 2022 | 14:56hConteúdo relacionado: RCT: Vasopressin + Methylprednisolone increase the likelihood of return of spontaneous circulation compared to placebo in patients with in-hospital cardiac arrest.
Comentário no Twitter
Systemic review and meta analysis post VAM-IHCA.
▶️ Moderate certainty for benefit with steroids and vasopressin on ROSC
▶️ Less certainty for longer term outcomes @mathiasholmb@LarsWAndersen1 @AsgerGranfeldthttps://t.co/K3jZ1gBs1h— Critical Care Reviews (@CritCareReviews) January 4, 2022
Revisão | Encefalopatia hepática: pensando além da amônia.
4 Fev, 2022 | 14:51hHepatic Encephalopathy: Thinking Beyond Ammonia – Clinical Liver Disease
Estudo randomizado | Em pacientes com artrite reumatoide, o tratamento com tofacitinibe por via oral aumenta o risco cardiovascular e de câncer, comparado ao tratamento com inibidores de TNF por via subcutânea.
4 Fev, 2022 | 14:51hCardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Vídeo: CV and Cancer Risk with Tofacitinib in RA – New England Journal of Medicine
Comentário: CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis – HealthDay
Estudo randomizado | Uma ampla avaliação geriátrica com “hospital em casa” pode ser uma alternativa custo-efetiva à internação hospitalar.
4 Fev, 2022 | 14:42hRevisão | Tratamento do risco de doença cardiovascular aumentado após desfechos adversos de gestação.
4 Fev, 2022 | 14:40hPrimary Care–Based Cardiovascular Disease Risk Management After Adverse Pregnancy Outcomes: a Narrative Review – Journal of General Internal Medicine (se o acesso a este link for pago, tente este)
Ver também: thread from the author on Twitter summarizing the article
Conteúdos relacionados:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
Cohort Study: Cardiovascular Disease After Hypertensive Disorders of Pregnancy Largely Explained by Conventional Cardiovascular Risk Factors (estudos recentes sobre o tema)
Revisão sistemática | Intervenções de autogerenciamento para pessoas com doença pulmonar obstrutiva crônica.
4 Fev, 2022 | 14:33hResumo: Self-management for people with chronic obstructive pulmonary disease – Cochrane Library
Comentário no Twitter
Graphical abstract for our new #Cochrane Review on #Self-management interventions for people with #COPD thanks to @jade_schrijver for drafting it and the epic review update https://t.co/4V7d9TUHMh pic.twitter.com/tgL67df9rg
— CochraneAirways (@CochraneAirways) January 17, 2022
Revisão | Tratamento multidisciplinar da lesão traqueobrônquica.
4 Fev, 2022 | 14:27hMultidisciplinary management of tracheobronchial injury – European Respiratory Review


